Clinical trial

Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate Cancer

NCT03085043

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

PROCEDURE · Unmapped registry intervention Bone Scan Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Computed Tomography Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Magnetic Resonance Imaging Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Magnetic Resonance Whole Body Diffusion-Weighted Imaging Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate Cancer

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2016-04-20

PhaseNA

Conditions

Prostate Carcinomaverified · MONDO: prostate carcinoma

Interventions

Bone ScanPROCEDURE

Computed TomographyPROCEDURE

Magnetic Resonance ImagingPROCEDURE

Magnetic Resonance Whole Body Diffusion-Weighted ImagingPROCEDURE

Sponsors & collaborators

M.D. Anderson Cancer Centerlead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

HoustonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03085043 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.